Brief: Peptonic Medical closes SEK 6 mln rights issue to group of new investors

Peptonic Medical AB

04/08/2016 12:59

Aug 4 (Reuters) - Peptonic Medical AB  PMED.ST : 
    * Said on Wednesday had completed a rights issue of 6 million Swedish crowns ($701,582.07) 
(before transaction costs equivalent to 10 pct of the total rights issue amount), to a selected 
group of new investors 
    * A total of 1,428,572 shares were issued at a subscription price of 4.20 crowns per share 
    * Proceeds from this rights issue will be used to start the preparations of the clinical 
phase 3 programme as well as to start preparing and conducting a pilot study on a new medical 
indication that is protected by patents proprietary to the Company 
    * The number of issued shares in the Company will increase by 1,428,572 to 20,602,984, 
corresponding to a share capital of 2,060,298.40 crowns as a result of this rights issue 
 
     
 Source text: http://bit.ly/2aWUdXN 
     
 Further company coverage:  PMED.ST   
    
 
 
 
($1 = 8.5521 Swedish crowns) 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))